A Cochrane review found benefit in lung function in people with COPD at least as good as that seen with twice-daily long-acting beta2-agonists.
Indacaterol
Abiraterone acetate
Olodaterol
Ingenol mebutate
Semagacestat
Quingestanol acetate
Dienogest
Bisoctrizole